Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3674142015 | Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
3674143013 | Product containing precisely bumetanide 500 microgram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Is a | Bumetanide and potassium chloride only product in oral dose form | true | Inferred relationship | Some | ||
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Plays role | Loop diuretic therapeutic role | true | Inferred relationship | Some | ||
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has BoSS | Bumetanide | true | Inferred relationship | Some | 1 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has precise active ingredient | Bumetanide | true | Inferred relationship | Some | 1 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has BoSS | Potassium chloride | true | Inferred relationship | Some | 2 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has precise active ingredient | Potassium chloride | true | Inferred relationship | Some | 2 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has manufactured dose form | Extended-release oral tablet | true | Inferred relationship | Some | ||
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Is a | Bumetanide-containing product in oral dose form | false | Inferred relationship | Some | ||
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Is a | Potassium chloride-containing product in oral dose form | false | Inferred relationship | Some | ||
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has precise active ingredient | Potassium chloride | false | Inferred relationship | Some | 1 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength numerator value | 500 | false | Inferred relationship | Some | 2 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength numerator unit | mcg | false | Inferred relationship | Some | 2 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has BoSS | Bumetanide | false | Inferred relationship | Some | 2 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has precise active ingredient | Bumetanide | false | Inferred relationship | Some | 2 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has BoSS | Potassium chloride | false | Inferred relationship | Some | 1 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength numerator value | 573 | false | Inferred relationship | Some | 1 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Unit of use quantity reference set
Description inactivation indicator reference set